Impact of changing US cigarette smoking patterns on incident cancer: Risks of 20 smoking-related cancers among the women and men of the NIH-AARP cohort by Freedman, Neal D et al.
Washington University School of Medicine
Digital Commons@Becker
Open Access Publications
2016
Impact of changing US cigarette smoking patterns
on incident cancer: Risks of 20 smoking-related
cancers among the women and men of the NIH-
AARP cohort
Neal D. Freedman
National Cancer Institute
Christian C. Abnet
National Cancer Institute
Neil E. Caporaso
National Cancer Institute
Joseph F. Fraumeni Jr.
National Cancer Institute
Gwen Murphy
National Cancer Institute
See next page for additional authors
Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs
This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been accepted for inclusion in Open
Access Publications by an authorized administrator of Digital Commons@Becker. For more information, please contact engeszer@wustl.edu.
Recommended Citation
Freedman, Neal D.; Abnet, Christian C.; Caporaso, Neil E.; Fraumeni, Joseph F. Jr.; Murphy, Gwen; Hartge, Patricia; Hollenbeck,
Albert R.; Park, Yikyung; Shiels, Meredith S.; and Silverman, Debra T., ,"Impact of changing US cigarette smoking patterns on incident
cancer: Risks of 20 smoking-related cancers among the women and men of the NIH-AARP cohort." International Journal of
Epidemiology.45,3. 846-856. (2016).
https://digitalcommons.wustl.edu/open_access_pubs/6502
Authors
Neal D. Freedman, Christian C. Abnet, Neil E. Caporaso, Joseph F. Fraumeni Jr., Gwen Murphy, Patricia
Hartge, Albert R. Hollenbeck, Yikyung Park, Meredith S. Shiels, and Debra T. Silverman
This open access publication is available at Digital Commons@Becker: https://digitalcommons.wustl.edu/open_access_pubs/6502
Smoking and Cancer
Impact of changing US cigarette smoking
patterns on incident cancer: risks of 20
smoking-related cancers among the women
and men of the NIH-AARP cohort
Neal D Freedman,1* Christian C Abnet,1 Neil E Caporaso,1
Joseph F Fraumeni Jr,1 Gwen Murphy,1 Patricia Hartge,1 Albert R
Hollenbeck,2 Yikyung Park,3 Meredith S Shiels1 and Debra T Silverman1
1Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA, 2AARP
(retired), Washington, DC, USA and 3Division of Public Health Sciences, Washington University School
of Medicine in St Louis, St Louis, MO, USA
*Corresponding author. Nutritional Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer
Institute, 9609 Medical Center Drive, MSC9768 Bethesda, MD 20892, USA. E-mail: freedmanne@mail.nih.gov
Accepted 12 August 2015
Abstract
Background: Historically, US women started smoking at a later age than men and had
lower relative risks for smoking-related cancers. However, more recent birth cohorts of
women and men have similar smoking histories and have now reached the high-risk age
for cancer. The impact of these changes on cancer incidence has not been systematically
examined.
Methods: Relative risks (RR), 95% confidence intervals (CI) and attributable fractions
were calculated for cigarette smoking and incidence of 20 smoking-related cancers in
186 057 women and 266 074 men of the National Institutes of Health-AARP cohort, aged
50 to 71 years in 1995 and followed for 11 years.
Results: In the cohort, which included participants born between 1924 and 1945, most
women and men started smoking as teenagers. RRs for current vs never smoking were
similar in women and men for the following cancers: lung squamous-cell (RR women:
121.4, 95% CI: 57.3–257.4; RR men:114.6, 95% CI: 61.2–214.4), lung adenocarcinoma (RR
women: 11.7, 95% CI: 9.8–14.0; RR men: 15.6, 95% CI: 12.5–19.6), laryngeal (RR women:
37.0, 95% CI: 14.9–92.3; RR men: 13.8, 95% CI: 9.3–20.2), oral cavity-pharyngeal (RR
women:4.4, 95% CI: 3.3–6.0; RR men: 3.8, 95% CI: 3.0–4.7), oesophageal squamous cell
(RR women: 7.3, 95% CI: 3.5–15.5; RR men: 6.2, 95% CI: 2.8–13.7), bladder (RR women:
4.7, 95% CI: 3.7–5.8; RR men: 4.0, 95% CI: 3.5–4.5), colon (RR women: 1.3, 95% CI: 1.2–1.5;
RR men: 1.3, 95% CI: 1.1–1.4), and at other sites, with similar attributable fractions.
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Conclusions: RRs for current smoking and incidence of many smoking-related cancers
are now similar in US women and men, likely reflecting converging smoking patterns.
Key words: Cigarette smoking, cohort, cancer, men and women
Introduction
The 1964, the US Surgeon General’s Report concluded
that cigarette smoking causes lung cancer in men.1 Later
studies extended these findings to women and to numerous
other cancer sites.2,3 However, dramatic subsequent
changes in smoking patterns2 may have affected the magni-
tude of smoking-related cancer risks.
In the 1920s, most US cigarette smokers were men who
had started smoking in their teenage years.4,5 In contrast,
cigarette smoking did not become common among women
until World War II. Furthermore, age at initiation tended
to be later in women than in men until the 1960s.4–6 These
birth cohorts have only recently reached the high-risk age
for cancer. Previous epidemiological studies largely
included women who started smoking later in life, and
therefore may underestimate the contemporary risks of
currently smoking women.6 Indeed, recent data for overall
mortality and the most common causes of death, including
mortality from lung cancer, indicate that the RRs for cur-
rent vs never smoking increased in US women over the
course of the 20th centuryto reach that of men.7 However,
few comparable data for the incidence of different cancer
types by sex are available.
Other historical changes may also have affected cancer
risks, including widespread use of filters, blended tobacco
and other changes to cigarettes.2,8,9 Such changes are thought
to have contributed to changes in the histological distribution
of lung cancer and also may have affected disease risks.
Contemporary smokers in the USA also tend to have lower
socioeconomic status than smokers of the past.10
We examined associations between cigarette smoking
and incidence of 20 smoking-related cancers3 in the
women and men of the NIH-AARP study,11 a large con-
temporary cohort in which most women and men began
smoking in their teenage years. To examine possible
changes in RRs over time, we systematically reviewed US
studies of smoking and histological subtype of lung cancer
(adenocarcinoma, small-cell, squamous-cell and undiffer-
entiated) and anatomical subtype of head and neck cancer
(larynx, oral cavity, and pharynx), sites with strong-associ-
ations and substantial previous literature.
Methods
Study population
The NIH-AARP (National Institutes of Health-AARP)
Diet and Health Study11 was initiated in 1995–96 when
a questionnaire was mailed to 3.5 million AARP mem-
bers between the ages of 50 and 71, who lived in:
California; Florida; Louisiana; New Jersey; North
Carolina; Pennsylvania; Atlanta, Georgia; or Detroit,
Michigan. Questionnaires were returned by 617 119 par-
ticipants, 566 398 of whom completed them in satisfac-
tory detail.
The NIH-AARP was approved by the Special Studies
Institutional Review Board of the NCI and participants
gave informed consent by virtue of completing and return-
ing the questionnaire.
We excluded proxy respondents (n¼ 15 760), those
with prevalent (except non-melanoma skin cancer) cancer
at baseline (n¼ 51 234), those lacking information on to-
bacco smoking (n¼ 31 867), those who did not smoke cig-
arettes but smoked pipes or cigars (n¼ 15 367) and those
Key Messages
• In the late 19th and early 20th centuries, US women typically started smoking cigarettes later in life than men and
tended to have lower relative risks for cigarette smoking and different types of incident cancer.
• By the 1960s, age at initiation in women had decreased to that of men. The NIH-AARP cohort is one of the first to in-
clude these birth cohorts of women, allowing direct comparisons of disease risks in men and women with largely
similar lifetime exposures.
• In the NIH-AARP cohort that included women and men with similar lifetime smoking histories, women and men had
similar relative risks for cigarette smoking and many types of incident smoking-related cancer.
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who died before their completed questionnaire was
scanned, which was set as the first day of follow-up
(n¼ 40). Our analytical cohort included 186 057 women
and 266 074 men.
Cohort follow-up
Cohort members were followed by annual updates to the
US Postal Service National Change of Address database
and participant change of address requests. Vital status
was assessed via the Social Security Administration Death
Master File and National Death Index.
‘Smoking-related cancers’, as defined by the
International Agency for Research on Cancer (IARC),3
were identified by the cancer registries of 11 states (eight
baseline states plus Arizona, Nevada and Texas).12 Site of
first primary incident cancer was defined using the
International Classification of Disease for Oncology site13
and oesophagus, lung and ovary histology codes. We also
combined cancers of the oral cavity and pharynx together
to facilitate comparisons with previous studies.
Follow-up time ended at incident cancer diagnosis,
death, movement out of the catchment area or
31 December 2006, whichever came first.
Exposure assessment
We assessed tobacco smoking, demographics and other ex-
posures via baseline questionnaire. Ever smokers were par-
ticipants who reported smoking 100 cigarettes during their
lifetime. We assessed the typical number of cigarettes
smoked per day, current or former smoking status and
years since cessation for former smokers. Participants re-
porting quitting in the previous year were considered to be
current smokers. To calculate duration of smoking, we
used data on age at initiation that were available for a ma-
jority of the cohort (n¼290 242; n¼ 152 644 ever smok-
ers) who answered a later questionnaire in 2004–06. For
those lacking age at initiation, we imputed 17 years as this
was the mid point of both female and male participants’
most common response category (15 to 19 years) and cor-
responds with national surveys. Pack-years of smoking
were determined by multiplying cigarettes per day by
smoking duration.
Statistical methods
Analyses were conducted using SAS version 9.1. Statistical
tests were two-sided. Age-standardized incidence rates per
100 000 person-years and 95% confidence intervals (CI)
were calculated for men and women separately, using
5-year age bands standardized to the entire NIH-AARP
study population.
Sex-stratified RRs and 95% CIs were obtained from
Cox proportional hazards regression models, with adjust-
ment for age, education, alcohol, self-reported ethnicity
and smoking pipes or cigars. We provide relative risks for
categories of smoking with three or more cases. Inclusion
of additional lifestyle and dietary variables, including: con-
sumption of fruits, vegetables and red meat; body mass
index; physical activity; and menstrual and reproductive
factors (women), had only minor effects on relative risks
and were excluded to facilitate comparisons with earlier
studies.
Population attributable fractions (AFs) for ever smoking
were calculated from multivariate-adjusted beta-
coefficients with 95% CIs.
Systematic review of previous studies
Due to strong associations between smoking and each
major histological subtype of lung cancer, as well as ana-
tomical sites of head and neck cancer, we systematically re-
viewed previous US studies of these associations to identify
temporal changes in relative risk. Details of our search and
selection criteria are provided in the Supplement (available
as Supplementary data at IJE online). We identified 21
lung cancer studies providing relative risks by histological
subtype and 24 studies of head and neck cancer that pro-
vided relative risks by anatomical sub-site. These studies
were conducted between 1949 and 2009.
Results
At baseline, 17% of women and 13% of men were current
smokers, and 44% of women and 26% of men were never
smokers (Supplementary Table 1, available as
Supplementary data at IJE online). Current smokers tended
to have less education than never smokers. Among partici-
pants with data on age of initiation, the most common cat-
egory of initiation was age 15–19 (43% of female and 41%
of male current smokers), although more men (33%)
started smoking before age 15 than women (16%). Few
men (2%) or women (6%) started smoking after age 25.
Incidence rates among current smokers were higher
than among never smokers for all 20 examined cancer sites
(Supplementary Tables 2–3, available as Supplementary
data at IJE online) in both women and men. Among female
current smokers, the highest incidence rates were observed
for lung cancer, followed by colon, bladder, pancreas, and
oral cavity and pharynx. Among male current smokers, the
most common cancers, in order, were lung, bladder, colon,
oral cavity and pharynx, and kidney. In general, incidence
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rates tended to be higher in men than women, among both
current smokers and among never smokers.
RRs for current vs never smoking nearly always reached
statistical significance, even for hypopharynx, renal pelvis
and other sites with relatively low incidence (Figure 1;
Supplementary Tables 2–3). The strongest associations were
observed for cancers of the respiratory tract, including lar-
ynx and lung; RRs for oesophageal squamous-cell, oral cav-
ity and urinary tract cancers also reached 4 or higher.
RRs for current smoking in women were largely com-
parable to that for men, with overlapping CIs (Figure 1;
Supplementary Tables 2–3). AFs for ever smoking were
also similar (Figure 1). We observed this pattern for major
lung cancer subtypes: squamous-cell (women, RR: 121.4,
95% CI: 57.3–257.4, AF for ever smoking: 97%; men,
RR: 114.6, 95% CI: 61.2–214.4, AF: 97%), small-cell
(women, RR: 73.1, 95% CI: 43.6–122.8, AF: 94%; men,
RR: 73.1, 95% CI: 41.1–130.2, AF: 94%), undifferenti-
ated (women, RR: 32.0, 95% CI: 15.4–66.2, AF: 89%;
men, RR: 39.5, 95% CI: 19.2–81.2, AF: 90%), adenocar-
cinoma (women, RR: 11.7, 95% CI: 9.8–14.0, AF: 74%;
men, RR: 15.6, 95% CI: 12.5–19.6, AF: 82%) and other
sites as well, although confidence intervals for less com-
mon sites were sometimes wide.
For example, similar RRs and AFs were observed in
women and men for oesophageal squamous-cell (women,
RR: 7.3, 95% CI: 3.5–15.5, AF: 56%; men, RR: 6.2, 95%
CI: 2.8–13.7, AF: 63%), oesophageal adenocarcinoma
(women, RR: 2.4, 95% CI: 1.0–5.9, AF: 37%; men, RR:
2.9, 95% CI: 2.1–4.1, AF: 44%), cancers of the bladder
(women, RR: 4.7, 95% CI: 3.7–5.8, AF: 52%; men, RR:
4.0, 95% CI: 3.5–4.5, AF: 52%), renal pelvis (women, RR:
7.0, 95% CI: 3.2–15.4, AF: 50%; men, RR: 4.2, 95% CI:
2.1–8.4, AF: 57%), oral cavity and pharynx (women, RR:
4.4, 95% CI: 3.3–6.0, AF: 46%; men, RR: 3.8, 95% CI:
3.0–4.7, AF: 36%), pancreas (women, RR: 2.3, 95% CI:
1.8–2.8, AF: 18%; men, RR: 2.0, 95% CI: 1.6–2.4, AF:
13%) and colon (women: RR: 1.3, 95% CI: 1.2–1.5, AF:
9%; men, RR: 1.3, 95% CI: 1.1–1.4, AF: 11%). Although
RRs were higher in men for some sites, such as liver (men,
RR: 2.7, 95% CI: 1.9–3.8, AF: 31%; women, RR: 1.6,
95% CI: 0.9–2.6, AF: 19%), RRs for others, such as lar-
ynx, were higher in women (women, RR: 37.0, 95% CI:
14.9–92.3, AF: 88%; men, RR: 13.8, 95% CI: 9.3–20.2,
AF: 74%).
We observed a dose-response for nearly all examined
sites, with higher incidence rates and RRs observed with
smoking more cigarettes per day. RRs for cigarettes per
day (Tables 1 and 2) and pack-years (Supplementary
Tables 4–5, available as Supplementary data at IJE online)
were generally similar between women and men for each
cancer site.
Similar patterns for current vs never smoking and each
incident cancer were also observed among each stratum of
educational status (Supplementary Tables 6–7, available as
Supplementary data at IJE online), although our confi-
dence intervals were often wide.
To evaluate possible historical changes, we compared
our results for lung, laryngeal, oral cavity and pharyngeal
cancers with previously published US studies by systematic
review (plotted chronologically in Figures 2 and 3 and
listed in Supplementary Tables 8–12, available as
Supplementary data at IJE online). As most previous stud-
ies combined cancers of the oral cavity and pharynx to-
gether, we did the same. In studies conducted before 1970,
that included participants born in the late 19th and early
20th centuries, RRs for current vs never smoking were
lower in women than in men (RRs for lung adenocarcin-
oma: 0.6–1.5 in women vs 1.5–4.6 in men; RRs for lung
squamous-cell cancer: 2.6 and 3.0 in women vs 8.3 and
22.9 in men; RRs for laryngeal cancer: 3.8 in women vs
5.8–23.4 in men; RRs for oral cavity and pharyngeal can-
cer: 2.0 and 2.6 in women vs 3.1–6.3 in men).
For women (Figure 2), RRs increased over time for each
of these cancer types (comparing RRs in studies conducted
prior to 1970 with the current study: lung adenocarcin-
oma: 0.6–1.5 vs 11.7; lung squamous-cell cancer: 2.6 and
3.0 vs 121.4; laryngeal cancer: 3.8 vs 37.0; and oral cavity
and pharyngeal cancer: 2.0 and 2.6 vs 4.4) and became
similar to RRs in men. Similar patterns were also seen for
small-cell lung cancer, although we identified fewer pre-
vious studies (Supplementary Table 8).
In contrast to trends among women, RRs for current vs
never smoking with laryngeal and oral cavity and pharyn-
geal cancer in men did not appear to change over time
(Figure 3). However, RRs for lung adenocarcinoma (for
example, 15.6 in the current study) and lung squamous-
cell cancer (114.6 in the current study) were higher in the
more recent studies than in earlier studies, as we had
observed for women. Similar patterns were again observed
for small-cell lung cancer.
In both women and men, increasing RRs for cigarette
smoking and lung cancer persisted among categories of cig-
arettes per day and pack-years of smoking (Supplementary
Tables 9 and 10).
Discussion
Relative risks for current smoking and each smoking-
related cancer were broadly similar in the women and men
of the NIH-AARP cohort, with largely overlapping confi-
dence intervals. In contrast, data from our systematic re-
view indicate substantially lower RRs in women relative to
men in US studies conducted before 1970, which included
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Hypopharynx
F
M
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
M
F
Lung squamous cell 7 285
10 575
Lung small cell
12 445
15 377
M
FLung undifferentiated
8 139
8 92
M
FLarynx
31 207
5 73
M
FLung adenocarcinoma
90 662
155 647
M
FEsophageal squamous cell
8 38
10 28
Ureter
8 23
6 9
Nasal cavity 10 10
8 19
Renal Pelvis
13 25
10 19
4 29
5 9
Bladder
M
F
411 736
131 199
Esophageal adenocarcinoma
65 91
10 10
Liver
70 83
46 22
Pancreas
213 194
213 152
Stomach
M
F
102 111
86 36
AML
M
F
63 61
48 24
Kidney
291 217
196 83
Colon
731 440
722 321
Rectum
249 188
245 115
Cervix F 56 45
Ovary (Mucinous) F 12 5
Site
Number of cases
Never
smoker
Current
smokerSex
Attributable fraction
for ever-smoking
(95%CI)
97 (93-98)
97 (94-98)
94 (90-96)
94 (89-96)
89 (78-94)
90 (80-95)
88 (73-95)
74 (64-82)
74 (69-77)
82 (78-86)
56 (25-77)
63 (31-82)
35 (0-71)
62 (29-82)
23 (0-58)
54 (18-77)
50 (17-73)
57 (29-76)
47 (0-79)
65 (19-88)
52 (44-59)
52 (47-56)
37 (0-67)
44 (30-56)
19 (0-38)
31 (15-46)
18 (8-27)
13 (2-23)
7 (0-23)
36 (24-48)
16 (0-35)
24 (5-40)
8 (0-18)
13 (4-22)
9 (3-14)
11 (5-17)
3 (0-13)
17 (8-27)
8 (0-27)
15 (0-48)
Nasopharynx
M
F
7 12
6 3 26 (0-67)
35 (0-72)
Oral Cavity
M
F
50 115
36 58 45 (27-60)
41 (24-56)
Oropharynx
M
F
64 103
22 50 51 (29-68)
28 (10-44)
Oral cavity and pharynx F
M
69 120
125 259
46 (33-57)
36 (25-47)
Relative risk
Figure 1. Associations of current vs never cigarette smoking with 20 smoking-related cancer sites in women and men. Relative risks on the log scale
are on the x-axis, with each cancer site listed on the y-axis. Plotted circles represent the point estimate and whiskers reflect the 95% confidence inter-
vals. Horizontal line represents a relative risk of 1. Relative risks are adjusted for age, education, alcohol intake, self-reported ethnicity and smoking
pipes or cigars. Never smokers are participants who did not smoke cigarettes, pipes or cigars. Attributable fractions and associated 95% confidence
intervals for ever smoking are also included.
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participants born in the late 19th and early 20th centuries,
for each major histological subtype of lung cancer, as well
as for cancers of the larynx and oral cavity and pharynx.
Before 1970, women at the ages of highest cancer risk
tended to start smoking later in life than men, and thus had
less cumulative exposure to cigarettes.4,5 Typical age at initi-
ation only reached that of men in the 1960s.4–6,14 The NIH-
AARP cohort is one of the first to include these more recent
birth cohorts of women, allowing direct comparisons of dis-
ease risks in men and women with largely similar lifetime
exposures. Our results indicate that the relative risks and
population-attributable fractions for cigarette smoking and
individual smoking-related cancers are now also similar for
men and women. Although systematic investigations of cig-
arette smoking and incident cancers among these birth co-
horts are not yet available from other US studies, we expect
our results to be confirmed as they parallel recent findings
for cigarette smoking with total and cause-specific mortal-
ity, which were consistent in our cohort and four others.7,15
Together, these results indicate that with converging
patterns of cigarette use, US female and male smokers now
have similar cigarette-related RRs for disease.
Unlike women, men have been initiating smoking as
teenagers for a century.4,5 Perhaps reflecting this pattern,
the RRs among men for laryngeal, oral cavity and pharyn-
geal cancer were stable over the years in our systematic
Table 1. Cigarettes per day among current smokers and cancer in women
Smoking use Nevera 1–10 cigarettes
per day
11–20 cigarettes
per day
20–40 cigarettes
per day
> 40 cigarettes
per day
Number in cohort 82 032 9784 13 513 8017 630
Cancer type Case
(n)
Case
(n)
Relative riskb
(95% CI)
Case
(n)
Relative riskb
(95% CI)
Case
(n)
Relative riskb
(95% CI)
Case
(n)
Relative riskb
(95% CI)
Oral cavity and pharynx 69 23 2.9 (1.8–4.8) 56 5.2 (3.6–7.4) 37 5.8 (3.8–8.8) 4 8.0 (2.9–22.2)
Oral cavity 36 8 2.2 (1–4.7) 30 5.6 (3.4–9.2) 20 6.5 (3.7–11.4) 0 nd
Oropharynx 22 11 3.8 (1.8–7.9) 21 5.3 (2.8–9.7) 15 6.1 (3.1–12.2) 3 15.2 (4.4–52)
Hypopharynx 5 1 nd 5 7.6 (2.1–27.1) 2 nd 1 nd
Nasopharynx 6 3 4.3 (1–17.9) 0 nd 0 nd 0 nd
Respiratory tract
Nasal cavity 10 1 nd 3 1.6 (0.4–5.9) 6 5.5 (1.9–16) 0 nd
Larynx 5 11 18.4 (6.3–53.3) 29 37.1 (14.3–96.6) 29 65.2 (24.9–170.9) 4 118.8 (31.4–449.4)
Lung 281 375 12.2 (10.4–14.2) 800 19.8 (17.3–22.7) 643 28.4 (24.6–32.8) 75 44.2 (34.2–57.2)
Lung adenocarcinoma 155 131 7.4 (5.9–9.4) 287 12.4 (10.2–15.2) 204 15.7 (12.7–19.5) 25 25.7 (16.8–39.4)
Lung small-cell 15 62 38.4 (21.8–67.6) 148 70.2 (41.2–119.7) 151 129.3 (75.7–220.7) 16 185.8 (91.4–377.7)
Lung squamous-cell 7 57 74 (33.7–162.6) 126 127.6 (59.5–273.9) 93 173.8 (80.3–376.3) 9 233.7 (86.6–630.6)
Lung undifferentiated 8 24 26.2 (11.7–58.6) 44 37 (17.3–79.2) 23 34.1 (15–77.4) 1 nd
Alimentary tract
Oesophageal squamous-cell 10 3 2.1 (0.6–8) 20 12.6 (5.7–28.1) 5 5.4 (1.8–16.7) 0 nd
Oesophageal adenocarcinoma 10 1 nd 3 1.6 (0.4–6.2) 6 5.4 (1.8–16.2) 0 nd
Stomach 86 10 1.1 (0.6–2.2) 17 1.6 (0.9–2.6) 7 1.2 (0.5–2.6) 2 nd
Colon 722 101 1.3 (1.1–1.6) 146 1.5 (1.2–1.8) 73 1.4 (1.1–1.7) 1 nd
Rectum 245 30 1.1 (0.7–1.6) 55 1.5 (1.1–2) 24 1.2 (0.8–1.8) 6 4.0 (1.7–9)
Liver 46 6 1.3 (0.5–3) 11 1.7 (0.9–3.4) 4 1.1 (0.4–3.2) 1 nd
Pancreas 213 58 2.6 (2.0–3.5) 60 2.1 (1.6–2.8) 32 2.0 (1.4–2.9) 2 nd
Urinary tract
Bladder 131 50 3.5 (2.5–4.9) 82 4.5 (3.4–5.9) 63 6.2 (4.5–8.4) 4 5.2 (1.9–14.1)
Renal pelvis 10 3 3.4 (0.9–12.4) 9 7.6 (3–19.3) 7 10.7 (3.9–29.4) 0 nd
Ureter 6 2 nd 5 6.3 (1.8–21.7) 2 4.3 (0.8–22.7) 0 nd
Kidney 196 25 1.1 (0.8–1.8) 36 1.3 (0.9–1.8) 18 1.2 (0.7–1.9) 4 3.5 (1.3–9.4)
Other
AML 48 12 2.4 (1.2–4.5) 8 1.1 (0.5–2.4) 4 1.0 (0.3–2.7) 0 nd
Cervical 56 14 2.1 (1.2–3.8) 16 1.9 (1.1–3.3) 15 3.2 (1.8–5.7) 0 nd
Ovary (mucinous) 12 2 nd 3 1.6 (0.4–5.8) 0 nd 0 nd
nd, not determined; AML, acute myeloid leukemia.
aReferent group: never smokers are participants who did not smoke cigarettes, pipes or cigars.
bAdjusted for age, education, alcohol intake, self-reported ethnicity and smoking pipes or cigars.
International Journal of Epidemiology, 2016, Vol. 45, No. 3 851
Downloaded from https://academic.oup.com/ije/article-abstract/45/3/846/2572572
by Denise Hannibal user
on 23 January 2018
review, whereas RRs among women strengthened over
time. In contrast, RRs for cigarette smoking and each
major histological subtype of lung cancer appeared to in-
crease in men over the course of the 20th century, as we
also observed for women. Such findings likely do not re-
flect changes in cigarette use per day. Higher RRs for lung
cancer in the more recent studies persisted within specific
levels of cigarettes per day or pack-years. Also, smokers in
our cohort tended to smoke fewer cigarettes per day than
in earlier US studies, reflecting similar declines for cigar-
ettes per day in the US population.5,16 Concordant with
our results, mortality rates for each of these histological
subtypes were higher in male current smokers in the
Cancer Prevention Study (CPS)-II, with follow-up from
1982 to 1984, than in CPS-I with follow-up from 1959 to
1961.8 Supporting these findings, modelling studies have
also shown that the relative risks from CPS-I underesti-
mated subsequent US lung cancer mortality rates, and in
particular the rise of lung adenocarcinoma.2,17,18
Analogous findings in the USA have been reported for
incident bladder cancer, in which associations with smok-
ing were stronger in the current cohort19 and the New
England Bladder Cancer Study20 than in previous studies.
Associations between smoking and total mortality also
strengthened in the USA and the UK over the 20th century
in both women and men.6,7,21,22
Strengthening associations between cigarette smoking
and some cancers may reflect widespread changes in the
design and construction of cigarettes.2,8 Such changes
could have affected both smoking behaviour and the distri-
bution of carcinogens present in tobacco smoke.9 These
changes might have differential effects across the spectrum
Table 2. Cigarettes per day among current smokers and cancer in men
Smoking use Nevera 1–10 cigarettes per day 11–20 cigarettes per day 21–40 cigarettes per day > 40 cigarettes per day
Number in cohort 68 748 7184 13 314 13 421 1982
Cancer type Case
(n)
Case
(n)
Relative riskb
(95% CI)
Case
(n)
Relative riskb
(95% CI)
Case
(n)
Relative riskb
(95% CI)
Case
(n)
Relative riskb
(95% CI)
Oral cavity and pharynx 125 32 2.4 (1.6–3.6) 89 3.6 (2.7–4.8) 117 4.5 (3.4–6.0) 21 5.4 (3.3–8.7)
Oral cavity 50 12 2.5 (1.3–4.8) 45 5.0 (3.2–7.7) 51 5.5 (3.6–8.4) 7 5.0 (2.2–11.2)
Oropharynx 64 18 2.7 (1.5–4.6) 31 2.4 (1.5–3.8) 44 3.2 (2.1–4.9) 10 4.9 (2.4–9.8)
Hypopharynx 4 1 nd 8 7.8 (2.2–27.3) 17 15.2 (4.7–48.4) 3 17.4 (3.6–83.2)
Nasopharynx 7 1 nd 5 2.8 (0.8–10.1) 5 3.2 (0.9–11.6) 1 nd
Respiratory tract
Nasal cavity 8 2 nd 9 7.6 (2.7–21.3) 7 5.9 (2.0–17.7) 1 nd
Larynx 31 28 9.4 (5.5–15.8) 72 13.1 (8.5–20.3) 87 16 (10.4–24.6) 20 26.2 (14.6–46.8)
Lung 175 299 17.3 (14.3–20.9) 851 27.9 (23.7–33) 1076 37.7 (32–44.4) 209 53.0 (43.2–65.2)
Lung adenocarcinoma 90 99 11.5 (8.5–15.4) 248 16.2 (12.6–20.8) 274 19.1 (14.9–24.5) 41 20.9 (14.3–30.6)
Lung small-cell 12 51 40.8 (21.6–77.1) 153 67.9 (37.5–123) 203 93.6 (51.9–168.9) 38 125.5 (65.0–242.3)
Lung squamous-cell 10 68 64.5 (33.0–126.0) 185 102.0 (53.7–193.7) 270 160.6 (84.9–303.7) 52 222.5 (112.3–440.9)
Lung undifferentiated 8 18 24.7 (10.6–57.9) 37 28.7 (13.1–62.6) 73 61.7 (29.1–130.6) 11 67.5 (26.6–171.0)
Alimentary tract
Oesophageal squamous-cell 8 4 3.2 (0.9–11) 12 6.0 (2.3–15.4) 19 9.7 (3.9–23.7) 3 9.8 (2.5–39.3)
Oesophageal adenocarcinoma 65 10 1.6 (0.8–3.3) 37 3.2 (2.1–5) 39 3.5 (2.2–5.4) 5 3.2 (1.3–8.1)
Stomach 102 27 2.5 (1.6–3.9) 38 2.1 (1.4–3.1) 43 2.5 (1.7–3.7) 3 1.3 (0.4–4.0)
Colon 731 93 1.3 (1.1–1.7) 161 1.3 (1.1–1.5) 161 1.3 (1.1–1.6) 25 1.4 (0.9–2.1)
Rectum 249 35 1.1 (0.8–1.7) 75 1.4 (1.0–1.8) 64 1.2 (0.9–1.6) 14 1.7 (1.0–3.0)
Liver 70 20 2.8 (1.7–4.8) 34 2.9 (1.8–4.5) 26 2.3 (1.4–3.8) 3 1.9 (0.6–6.1)
Pancreas 213 39 1.7 (1.2–2.5) 63 1.6 (1.2–2.2) 78 2.1 (1.6–2.8) 14 2.6 (1.5–4.6)
Urinary tract
Bladder 411 122 3.2 (2.6–4.0) 284 4.2 (3.5–4.9) 288 4.4 (3.7–5.2) 42 4.6 (3.3–6.4)
Renal pelvis 13 4 4.2 (1.3–13.5) 12 6.9 (2.9–16.3) 8 4.9 (1.9–12.9) 1 nd
Ureter 8 3 4.7 (1.2–18.4) 13 10.5 (4.1–26.6) 7 5.6 (1.9–16.4) 0 nd
Kidney 291 53 1.9 (1.4–2.6) 67 1.4 (1.0–1.8) 88 1.9 (1.4–2.4) 9 1.4 (0.7–2.7)
Other
AML 63 13 2.1 (1.1–3.9) 23 2.1 (1.3–3.6) 23 2.3 (1.4–3.9) 2 nd
nd, not determined; AML, acute myeloid leukemia.
aReferent group: never smokers are participants who did not smoke cigarettes, pipes or cigars.
bAdjusted for age, education, alcohol intake, self-reported ethnicity and smoking pipes or cigars.
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of tobacco-related cancers, suggesting an explanation for
higher smoking-related risks of lung and bladder cancer in
men yet constant risks of laryngeal, oral cavity and pharyn-
geal cancer. Recent data suggesting specific associations
between certain tobacco-specific nitrosamines and particu-
lar forms of cancer23 support this hypothesis.
As cancers of the head and neck are additionally caused
by alcohol24 and human papillomavirus (HPV),25 it is also
possible that historical changes in these or possibly other
risk factors may have obscured the effects of changing cig-
arettes on these sites. As our study lacked biological sam-
ples, we were unable to test for HPV or other cancer risk
factors requiring biological samples such as Helicobacter
pylori, hepatitis B and hepatitis C. Future studies that in-
clude biological samples are needed to examine associ-
ations of cigarette smoking and cancer in the context of
these risk factors in contemporary birth cohorts of women
and men.
Higher RRs of certain smoking-related cancers could
also reflect decreasing incidence rates in never smokers,
which would cause the RRs for smoking to increase even if
absolute risks were unchanged. However, data from three
consortial projects7,26,27 indicate that the rates of lung can-
cer in never smokers remained constant, or possibly
1950 1960 1970 1980 1990 2000 1950 1960 1970 1980 1990 2000
1950 1960 1970 1980 1990 2000 1950 1960 1970 1980 1990 2000
(a) Lung adenocarcinoma (b) Lung squamous cell
(d) Oral cavity and pharynx(c) Larynx
Figure 2. Current cigarette use and lung and head and neck cancer by study year, in women. Relative risks for current vs never smoking are plotted
on the y-axis, using a log scale. Year is on the x-axis. Plotted circles represent the point estimate and whiskers reflect the 95% confidence intervals.
Each study is plotted by the mid point of when it was conducted, and labelled with the first author of the associated publication. Horizontal line repre-
sents a relative risk of 1. (a) Lung adenocarcinoma; (b) lung squamous cell carcinoma; (c) larynx; (d) oral cavity and pharynx.
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increased, over the ast 50 years. Other factors, such as in-
creases in fine particulate air pollution (PM2.5), may also
have influenced lung cancer trends in never smokers, par-
ticularly trends in adenocarcinoma.28
Current smokers in the US population tend to have less
education than never smokers and this was reflected in our
cohort. Concerns have been raised that such differences
could confound associations between smoking and
cancer.29 However, we observed strong associations
between smoking and cancer across strata of educational
status, suggesting socioeconomic differences between
smokers and non-smokers had little effect on our relative
risks.
Strengths of our study include prospective assessment of
cigarette use and very large size, allowing examination of
nasopharynx, ureter and other relatively uncommon can-
cers that are rarely investigated in prospective cohort stud-
ies. We examined incident cancers, important as cigarette
smoking can affect both cancer development and sur-
vival,30 and comparisons of incident cancer are less af-
fected by historical changes in treatment than are studies
of cancer mortality. Unlike most mortality studies, we
were able to investigate associations between cigarette
smoking and specific histological subtypes of oesophageal
and lung cancer, observing associations of substantially
different magnitude for each subtype. Inclusion of both
1950 1960 1970 1980 1990 2000 1950 1960 1970 1980 1990 2000
1950 1960 1970 1980 1990 2000 1950 1960 1970 1980 1990 2000
(a) Lung adenocarcinoma (b) Lung squamous cell
(d) Oral cavity and pharynx(c) Larynx
Figure 3. Current cigarette use and lung and head and neck cancer by study year, in men. Relative risks for current vs never smoking are plotted on
the y-axis, using a log scale. Year is on the x-axis. Plotted circles represent the point estimate and whiskers reflect the 95% confidence intervals. Each
study is plotted by the mid point of when it wasconducted, and labelled with the first author of the associated publication. Horizontal line represents a
relative risk of 1. (a) lung adenocarcinoma; (b) lung squamous cell carcinoma; (c) larynx; (d) oral cavity and pharynx.
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women and men allowed us to directly compare risks be-
tween them.
Limitations include a lack of information on smoking
initiation for the full cohort and assessment of smoking at
only a single time-point. During follow-up, some current
smokers probably quit, which would attenuate observed
associations for current smoking. However, as our RRs
were only moderately higher in analyses restricted to the
first 6 years of follow-up (data not shown), we present re-
sults for the entire follow-up period to maximize statistical
power. Also, our results may not apply to other popula-
tions with different smoking prevalence and different cig-
arette composition. For example, recent data from the
European Prospective Investigation into Cancer cohort re-
vealed lower RRs in women than men for current smoking
and different cancer types,31 likely reflecting less lifetime
smoking history in the women relative to the men of this
cohort. However, our results do likely apply to the UK and
other countries where women and men have similar smok-
ing patterns.
In conclusion, our data indicate that falling age of
smoking initiation in women and other historical changes
in US cigarette smoking patterns have altered associations
with incident cancer. With now similar lifelong smoking
patterns, relative risks and population-attributable frac-
tions for cigarette smoking and cancer in women are now
broadly similar to those found in men. Cigarette smoking
remains a critical determinant of cancer in the USA and
elsewhere. Further reductions in cigarette smoking are ur-
gently needed.
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